FDA禁止六歲以下服用感冒藥原因
不是因為藥削弱小朋友抵抗力(感冒藥沒有這種恐怖的成份)
而是多數在美國使用的感冒藥抗組織胺diphenhydramine, brompheniramine or chlorpheniramine
對兩歲以下小朋友來說成份過量
有部份case因為服用感冒藥造成神經系統問題
像是心律失調~呼吸困難或是其他嚴重的神經系統併發症問題
嚴重者會造成死亡
會說六歲以下的原因是因為"保守評估的結果"
所以規定六歲以下禁止使用
我老爸行醫四五十年
他一直灌輸我一個非常重要的觀念
小孩生病發燒"一定"要帶去看醫生
如果只是一般感冒
吃不吃藥沒關係
至少知道小朋友生病是因為感冒
千萬不要以自己的主觀認知去判斷小朋友發生了什麼事
(發燒=感冒 咳嗽=感冒 過幾天就會好)
畢竟醫師才是專業
以上給大家參考....
Drug Makers Withdraw Cough, Cold Meds for Infants
--------------------------------------------------------------------------------
Move comes as U.S. regulators scrutinize safety of products linked to dozens of deaths
By Steven Reinberg, HealthDay Reporter
THURSDAY, Oct. 11 (HealthDay News) -- Leading drug makers announced a voluntary withdrawal Thursday of oral cough and cold medicines marketed for use in infants.
The move affects only "infant" oral medicines, not those intended and labeled for use in children age 2 and older. And it comes as U.S. regulators review the products' safety, following reports of dozens of deaths since 1969.
"The reason the makers of over-the-counter, oral cough and cold medicines for infants are voluntarily withdrawing these medicines is that there have been rare patterns of misuse leading to overdose recently identified, particularly in infants, and safety is our top priority," Linda A. Suydam, president of the Consumer Healthcare Products Association (CHPA), said in a prepared statement.
The move was applauded by health experts in the field.
"Recalling the products until the public and health care providers are fully educated about the safety and effectiveness of these products is the right thing to do right now," said Catherine Tom-Revzon, the clinical pharmacy manager at Children's Hospital at Montefiore in New York City.
She added, "Combination products are dangerous if parents do not know what ingredients are in them and extra doses of single ingredients are given. Children under two are at higher risk for side effects compared to older children. What's worse is that infants can't tell us if their hearts are racing or they are overly drowsy."
According to the CHPA, the cough and cold medicines that are being withdrawn are:
[b][color=Black]Dimetapp(R) Decongestant Plus Cough Infant Drops
Dimetapp(R) Decongestant Infant Drops
Little Colds(R) Decongestant Plus Cough
Little Colds(R) Multi-Symptom Cold Formula
PEDIACARE(R) Infant Drops Decongestant (containing pseudoephedrine)
PEDIACARE(R) Infant Drops Decongestant & Cough (containing pseudoephedrine)
PEDIACARE(R) Infant Dropper Decongestant (containing phenylephrine)
PEDIACARE(R) Infant Dropper Long-Acting Cough
PEDIACARE(R) Infant Dropper Decongestant & Cough (containing phenylephrine)
Robitussin(R) Infant Cough DM Drops
Triaminic(R) Infant & Toddler Thin Strips(R) Decongestant
Triaminic(R) Infant & Toddler Thin Strips(R) Decongestant Plus Cough
TYLENOL(R) Concentrated Infants' Drops Plus Cold
TYLENOL(R) Concentrated Infants' Drops Plus Cold & Cough.[/color][/b]
Last month, U.S. health experts urged the federal Food and Drug Administration to consider banning the sale of over-the-counter cough and cold medicines for young children. The recommendation, from FDA safety officials, would apply to decongestant use in children under 2, and antihistamines in those younger than 6, according to FDA documents.
An FDA advisory panel is scheduled to consider the recommendation during a meeting on Oct. 18 and 19, and will then offer an opinion to the full agency. The FDA typically follows the recommendations of its advisory boards but is not required to do so.
In the safety review released Sept. 28, the FDA experts recommended that all infant cough and cold products be removed from the market. They also recommended that the sizes of the droppers, cups and syringes packaged with products be standardized to reduce the possibility of confusion and overdose, The New York Times reported.
An FDA review of records filed with the agency between 1969 and September 2006 found 54 reports of deaths in children associated with decongestant medicines made with pseudoephedrine, phenylephrine or ephedrine. It also found 69 reports of deaths associated with antihistamine medicines containing diphenhydramine, brompheniramine or chlorpheniramine, the Associated Press reported.
Most of the deaths involved children younger than 2.